isatin has been researched along with Myocardial Ischemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beckius, GE; Chapman, JG; Magee, WP; Milici, AJ; Stukenbrok, HA; Tracey, WR | 1 |
1 other study(ies) available for isatin and Myocardial Ischemia
Article | Year |
---|---|
A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Caspase 3; Caspase 7; Caspase Inhibitors; Caspases; Cell Line; Cells, Cultured; Coronary Circulation; Cysteine Proteinase Inhibitors; Dipeptides; Dose-Response Relationship, Drug; Heart Rate; In Situ Nick-End Labeling; Isatin; Ketones; Male; Microscopy, Electron; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Pyrrolidines; Rabbits | 2002 |